AVTOZMA

TOCILIZUMAB · CELLTRION USA, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AVTOZMA, covering 2025-01-24 to 2026-06-09. Get the full timeline:

Most recent: EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.